Company Information

CIN

Status

Date of Incorporation

31 March 2014

Listing Status

Unlisted

State

Ahmedabad

ROC

ROC Ahmedabad

Industry

Sub Category

Non-govt company

Last Balance Sheet

31 March 2023

Last Annual Meeting

30 September 2023

Paid Up Capital

700,000

Authorised Capital

1,000,000

Financials All Documents available from MCA @Rs 199/-

Directors

Pravinbhai Govindbhai Vekariya

Director/Designated Partner
over 1 year ago

Pareshkumar Ramjibhai Dhameliya

Director/Designated Partner
over 1 year ago

Haresh Karamashibhai Intaliya

Director/Designated Partner
over 3 years ago

Vijay Premjibhai Narola

Director/Designated Partner
over 3 years ago

Mukeshkumar Bhupatbhai Padsala

Director/Designated Partner
over 3 years ago

Ghanshyam Parsottambhai Laheri

Director
almost 11 years ago

Past Directors

Ghanshyam Keshavbhai Patel

Director
over 8 years ago

Kavitaben Vinodbhai Vaghasia

Director
over 9 years ago

Urvashiben Ashish Goti

Director
over 9 years ago

Rashmiben Kishorkumar Padsala

Director
over 9 years ago

Paras Ghanshyam Patel

Director
over 9 years ago

Manojbhai Nanubhai Gajera

Director
over 9 years ago

Kishorbhai Dhanjibhai Hirpara

Director
over 9 years ago

Himatbhai Karmshibhai Dholiya

Director
over 9 years ago

Dhirubhai Haribhai Polra

Director
over 9 years ago

Bhadresh Jerambhai Chhabhadiya

Director
over 9 years ago

Ashish Rameshchandra Pandya

Additional Director
over 9 years ago

Pareshkumar Kurjibhai Dhandhukiya

Additional Director
over 9 years ago

Kishorkumar Maganbhai Kachhadiya

Additional Director
over 9 years ago

Hetalben Dipakbhai Bhadiyadara

Additional Director
over 9 years ago

Dineshbhai Labhubhai Kheni

Additional Director
over 9 years ago

Bhagwanbhai Bhimjibhai Dhameliya

Director
almost 11 years ago

Ashaben Hareshbhai Intaliya

Director
almost 11 years ago

Sheetal Mukeshkumar Padsala

Director
almost 11 years ago

Dipal Paresh Dhameliya

Director
almost 11 years ago

Jaysukh Manjibhai Lakhani

Director
almost 11 years ago

Registered Trademarks

Im 11 Lupitas Pharmaceuticals

[Class : 5] Ayurvedic Preparation.

Emolup Av With Device Of Drops,... Lupitas Pharmaceuticals

[Class : 5] Pharmaceuticals Preparation In Class 05.

Prolanz With Device Of Boy... Lupitas Pharmaceuticals

[Class : 5] Pharmaceuticals Preparation In Class 5

Renewal of trademark is due. Renewal request in prescribed form is to be filed by the applicant.

View +4 more Brands for Lupitas Pharmaceuticals Private Limited.

Documents

Form ADT-1-02112020_signed

Optional Attachment-(1)-02112020

List of share holders, debenture holders;-02112020

Directors report as per section 134(3)-02112020

Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-02112020

Copy of written consent given by auditor-02112020

Copy of the intimation sent by company-02112020

Copy of resolution passed by the company-02112020

Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-02112020

Approval letter of extension of financial year or AGM-02112020

Approval letter for extension of AGM;-02112020

Form MGT-7-02112020_signed

Form AOC-4-02112020_signed

Form DPT-3-01102020-signed

Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-19102019

List of share holders, debenture holders;-19102019

Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-19102019

Directors report as per section 134(3)-19102019

Form MGT-7-19102019_signed

Form AOC-4-19102019_signed

Form DPT-3-20062019-signed

-14062019

Optional Attachment-(1)-14062019

Auditor?s certificate-14062019

Form DIR-12-22052019_signed

Notice of resignation;-21052019

Evidence of cessation;-21052019

Optional Attachment-(1)-21052019

Form MGT-14-18112018_signed

Copy(s) of resolution(s) along with copy of explanatory statement under section 173-18112018